US bans imports from 3 Chinese biotech companies over forced labor allegations

The Trump administration announced on Wednesday that it would be blocking shipments from three Chinese biotech companies – BGI Group, BGI Genomics, and MGI Tech – due to allegations of forced labor in China's Xinjiang region. These companies, which specialize in genetic sequencing technologies, are accused of sourcing materials or collaborating with the regional government to "recruit, transport, transfer, harbor, or receive forced labor" of Uyghurs and other persecuted ethnic groups in Xinjiang.

The Department of Homeland Security stated that the companies have "credible information" supporting these claims, as the collection and analysis of genetic material is used to monitor, surveil, and repress ethnic minorities in the region. The new trade actions come as biotechnology becomes an increasingly important battleground in the economic and technological rivalry between the U.S. and China.

BGI Group, the parent company, denied the allegations, stating that it has "not engaged in any form of forced labor" and "firmly opposes all forms of forced labor."